Neurizon Therapeutics Limited (ASX: NUZ), formerly known as PharmAust, is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.  Neurizon strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications. Through international collaborations and rigorous clinical programs, Neurizon is dedicated to creating new horizons for patients and families impacted by complex neural disorders. 

Biotechnology

Neuroscience

Therapeutics

Neurizon

Neurizon's headquarters in South Melbourne, Australia

This department fosters collaborations and partnerships within the scientific and medical communities to enhance advocacy and research efforts.

Scientific Relations

This department oversees governance and strategic direction for the organization.

Board Leadership

This department provides strategic direction and governance for the organization.

Executive Leadership

This department focuses on promoting the organization and driving business growth through strategic marketing and partnerships.

Marketing and Development

This department oversees organizational operations and ensures adherence to regulatory standards.

People (0)

Jobs (0)

Other teams

Board Leadership

Executive Leadership

Marketing and Development

Operations and Compliance